ARCHIVES

Cancer Research Faces A “Strategic Inflection,” NCI Director Says

This article is from The Cancer Letter archive.

Vol. 28 No. 16 | April 19, 2002

Download PDF Visit The Full Archive

Related Articles

No Difference in Toxicity Between IMRT and PRT In Medicare Patients

January 25, 2013

Support Contracts For Management Info, ODQ Updating Ok’d

October 12, 1990

NCCS Begins Program To Help Develop Survivors’ Care Plan

February 27, 2009

Insurers Increasingly Willing To Cover ABMT For Breast Cancer, GAO Finds

June 7, 1996

ColoPrint Improves Prognosis In Stage II and III Colon Cancer

January 28, 2011

Editorial: Ambiance Through Exclusion

May 20, 1994